2021
DOI: 10.1016/j.ajpath.2021.02.019
|View full text |Cite
|
Sign up to set email alerts
|

Gut-Lung Dysbiosis Accompanied by Diabetes Mellitus Leads to Pulmonary Fibrotic Change through the NF-κB Signaling Pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 31 publications
(18 citation statements)
references
References 73 publications
(59 reference statements)
0
17
0
1
Order By: Relevance
“…Diabetes is characterized by considerable morbidity and mortality, mainly from cardiovascular and renal complications, and it is well known that diabetes predisposes to a variety of infectious diseases, including pneumonia [30]. Studies have also shown that the lungs can be a target of diabetic complication where related pathologic findings include inflammatory cell infiltration and increased fibrosis [31,32]. In a study using mice with DM, it was reported that DM-related dysbiosis of gut-lung axis activates the NF-κB signaling pathway that leads to fibrotic changes in the lung tissue [31].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Diabetes is characterized by considerable morbidity and mortality, mainly from cardiovascular and renal complications, and it is well known that diabetes predisposes to a variety of infectious diseases, including pneumonia [30]. Studies have also shown that the lungs can be a target of diabetic complication where related pathologic findings include inflammatory cell infiltration and increased fibrosis [31,32]. In a study using mice with DM, it was reported that DM-related dysbiosis of gut-lung axis activates the NF-κB signaling pathway that leads to fibrotic changes in the lung tissue [31].…”
Section: Discussionmentioning
confidence: 99%
“…Studies have also shown that the lungs can be a target of diabetic complication where related pathologic findings include inflammatory cell infiltration and increased fibrosis [31,32]. In a study using mice with DM, it was reported that DM-related dysbiosis of gut-lung axis activates the NF-κB signaling pathway that leads to fibrotic changes in the lung tissue [31]. However, there are few studies on DM and airway dysbiosis and therefore further research on the respiratory microbiome and the pathologic changes in the airway would be necessary to better understand the impact of DM on the respiratory microbiome [33].…”
Section: Discussionmentioning
confidence: 99%
“…The sections were counter-stained with 4′-6-diamidino-2-phenylindole (DAPI, 5 ​μg/mL, Life Tech, USA) to reveal the nuclei and finally photographed by an Olympus IX51 microscope (Olympus, Tokyo, Japan). The immunofluorescent intensity was quantitative measured as previously described [ 37 , 38 ]. The results were analyzed using IPP 5.0 or image J software.…”
Section: Methodsmentioning
confidence: 99%
“…The lung microbiome has been reported to change in different conditions including metabolic diseases [ 79 ], asthma [ 80 ], COPD [ 81 ], pulmonary cystic fibrosis [ 82 ], and cancer [ 83 ]. During infections, these changes can be produced by the entry of a pathogen, an increase of pathobionts, loss of commensals or keystone taxa [ 55 , 56 ].…”
Section: Human Microbiome and Its Importance In Health And Diseasementioning
confidence: 99%